These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12552080)

  • 1. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
    Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
    J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
    Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
    Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review.
    Schuuring E
    Gene; 1995 Jun; 159(1):83-96. PubMed ID: 7607576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the EMS1 gene and its product, human Cortactin.
    Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
    Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
    Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
    Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
    Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
    Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines.
    Campbell DH; deFazio A; Sutherland RL; Daly RJ
    Int J Cancer; 1996 Nov; 68(4):485-92. PubMed ID: 8945620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
    Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
    Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
    Schuuring E; Verhoeven E; Litvinov S; Michalides RJ
    Mol Cell Biol; 1993 May; 13(5):2891-98. PubMed ID: 8474448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.